[BREAKING] Hemerion obtains the FDA clearance for its next US clinical trial

Kick-off of phase I clinical trial: INDYGO

For the first time, our technology combining a photosensitizing drug and an innovative photonic device is delivered upfront, during the surgery of patients newly diagnosed with glioblastoma. 
Indygo is a Phase I study sponsored by the University Hospital of Lille.
CHU Lille Logo